BIOL3216 / Interactive physiology

Life at Altitude

Hypobaric hypoxia · ventilation · acid–base · oxygen transport

V1 · Final Release

01Altitude

Landmarks select an elevation, not an expedition route.

Use Up or Right for the next higher landmark, Down or Left for the next lower landmark, Home for sea level and End for Everest summit. You can also select a named landmark.

04Scientific view

Save the current scientific state as the single retained Comparison. Saving again replaces the retained state.
Comparison

Current:

Explore the mechanismsIllness · pressure · compensation · comparison

Understand the relationship

Model assumptions & limits

An illustrative healthy resting lowlander adult. The climber illustrates terrain and breathing equipment; it does not imply exercise or illness.

Environment and scenarios

Reference atmosphere: This simulator uses one continuous pressure–altitude relationship across the schematic mountain. Real pressure at the same elevation varies with latitude, season, temperature and weather. Named landmarks provide elevation context, not exact local atmospheric conditions. Altitude selects a discrete scenario, not expedition history. Selecting a lower altitude does not model physiological de-acclimatization or recovery after real descent.

Supported physiology

Calgary is the low-altitude physiological reference. Mount Columbia, Pheriche and Everest Base Camp have calibrated Arrival, Developing and Established states. Sea level is the healthy resting teaching reference (40.0 mmHg CO₂ / 24.0 mmol/L HCO₃⁻), and the opening/Reset state. Its pH is calculated, not forced to 7.400. Calibrated Arrival → Established physiology ends at EBC. Mount Logan and Everest use separate literature-informed extreme-altitude references, with component-specific limits. The 2,500 m and 8,000 m markers are context only, not selectable scenarios or disease thresholds.

Acclimatization and hemoglobin

Arrival represents rapid exposure; Developing and Established are representative states, not fixed day counts. The DKB paper2016 affinity model uses fixed 37°C and reference BPG (0.00465 mol/L). Affinity represents the acid–base-dependent component, not complete whole-blood acclimatization.

100% O₂

Idealized FiO₂ = 1.00 immediate inspired-mixture challenge; real delivered FiO₂ varies with equipment, flow, leaks, ventilation and activity. Initially PaCO₂, HCO₃⁻, pH, P50 and Davenport state stay fixed. Slower ventilatory and renal responses are not modeled. The 50-mmHg hyperoxic effective correction applies to Sea-level reference and the existing Calgary–EBC calibrated states. It is a teaching approximation, not a universal A–a gradient. It is never applied to either extreme reference.

Lower teaching panels

AMS, HAPE and HACE are information only, not predicted illness states or a required progression. Gamow applies +2 psi (~103.43 mmHg) local pressure with ambient air; pressure-equivalent altitude is derived, physical altitude stays fixed, and only environmental oxygen pressures are calculated. Treatment outcome, pumping, CO₂ accumulation and field feasibility are not modeled. Diamox is a qualitative renal/ventilatory explanation without a calculated response magnitude. Descent & oxygen guides use of the existing controls; it applies no treatment.

Comparison and Reset

Comparison is one frozen scientific snapshot, not a baseline, physiological history or treatment trajectory. Reset restores the opening application state, not physiological recovery.

Not modeled

Exercise physiology, illness risk or diagnosis, treatment efficacy, expedition history, full hematological acclimatization and detailed tissue PO₂.

Scientific basis and provenance

Course materials guide teaching alignment. Approved empirical calibration pairs define representative acid–base states; they are not independent validation. Reference-atmosphere, gas-pressure and Henderson–Hasselbalch outputs are model-derived. Hemoglobin affinity and saturation use the published DKB paper2016 framework with the approved fixed assumptions. Lower-panel explanations follow the approved altitude-illness, Gamow, Diamox and Descent & Oxygen science audits.

Model record: Planning & Decision Record v0.3; Core Model Verification v0.1, corrected PASS after the documentation-only P50 rounding erratum; SA1 state architecture. No physiological parameter was retuned. This is a pedagogical teaching model, not a fully validated clinical or research simulation.

Sea-level reference and geographic context · v1.0

Sea level is the student-facing default and fixed Davenport reference. The canonical 40/24 inputs are healthy-resting teaching values, not a measured cohort tuple. pH is equation-derived; 5-mmHg air and 50-mmHg oxygen corrections are effective teaching assumptions. PaO₂ and SaO₂ are model-derived, not values expected in every healthy individual.

Calgary retains its 38.4/24.4 pair and historical role in acute-buffer construction and developing-state interpolation. The sea-level display reference does not re-fit Mount Columbia, Pheriche or EBC. Extreme-reference science and null boundaries are unchanged.

[S1] U.S. National Library of Medicine. Arterial Blood Gas (ABG) Test. MedlinePlus, updated 26 June 2025. PaCO₂ 35–45 mmHg and HCO₃⁻ 22–26 mEq/L support choosing familiar 40/24 teaching inputs; this source does not measure the chosen tuple. For monovalent bicarbonate, mEq/L and mmol/L are numerically equal. MedlinePlus ABG reference
MedlinePlus ABG reference

[S2] Mellemgaard K. The alveolar-arterial oxygen difference: its size and components in normal man. Acta Physiologica Scandinavica. 1966;67:10–20. DOI 10.1111/j.1748-1716.1966.tb03281.x. Primary abstract inspected: normal A–a differences vary with age and their physiological components. It does not validate the selected 5- or 50-mmHg constants. Primary abstract
Primary abstract

[S3] Smit B et al. Hyperoxia does not affect oxygen delivery in healthy volunteers while causing a decrease in sublingual perfusion. Microcirculation. 2018;25:e12433. DOI 10.1111/micc.12433. Primary article inspected via a full-text copy; n = 15, staged hyperoxia. Used to delimit the fixed-CO₂ approximation and protocol dependence, not to fit a new A–a rule. Article DOI · Full-text copy inspected
Article DOI · Full-text copy inspected

[S4] Dash RK, Korman B, Bassingthwaighte JB. Simple accurate mathematical models of blood HbO₂ and HbCO₂ dissociation curves at varied physiological conditions. European Journal of Applied Physiology. 2016;116:97–113. DOI 10.1007/s00421-015-3228-3. Inherited equation authority through P2 and P3; no model substitution or new Hb review. Inherited primary source
Inherited primary source

[G1] Natural Resources Canada, Canadian Geographical Names Database. Official place points: Calgary 51.0458333, −114.0574999; Mount Columbia 52.1475, −117.4405556; Mount Logan 60.5671, −140.4053544. Coordinates are rounded for context and are not physiological sampling locations. Calgary IAKID · Columbia IARVZ · Logan KADTU
Calgary IAKID · Columbia IARVZ · Logan KADTU

[G2] City of Calgary. Water pressure. Municipal explanation states that elevations across the city vary by almost 300 metres. The simulator’s 1,045-m input is retained from P1/P2; it is not derived from the city-centre coordinate. Municipal source
Municipal source

[G3] Statistics Canada. Table 15.3, Selected principal heights, by province and territory (2011), sourced to the Natural Resources Canada Atlas. Lists Mount Columbia 3,747 m on the Alberta–British Columbia border as Alberta’s highest, and Mount Logan 5,959 m as Canada’s highest. Archived geographic reference, consistent with retained inputs. Principal heights table
Principal heights table

[G4] Parks Canada. Nature and science, Kluane National Park and Reserve. Supports Mount Logan’s St. Elias Mountains and Yukon park context and its status as Canada’s highest mountain. Kluane nature and science
Kluane nature and science

[G5] Himalayan Rescue Association. Pheriche Aid-Post and Potential Volunteers. Supports the Khumbu aid post, care and altitude-illness education. The volunteer page describes its clinic at 4,250 m; this is not a replacement for the approved 4,300-m model landmark. Pheriche aid post · Clinic elevation context
Pheriche aid post · Clinic elevation context

[G6] UCAR Earth Observing Laboratory. CEOP Himalayas, Pheriche station metadata. Lists 27°53′43.3″ N, 86°49′7.5″ E and 4,258 m for a particular weather station. Used to distinguish station metadata from village context and the retained 4,300-m simulation input. Station metadata
Station metadata

[G7] OpenStreetMap place points as displayed by Mapcarta: Pheriche village, node 1303891304, 27.8934, 86.8200; South Everest Base Camp, node 5225912921, 27.99967, 86.8488. Community map context, not surveyed physiological sites. Rounded card coordinates identify the village and general camp area. Pheriche village · South base camp area
Pheriche village · South base camp area

[G8] Nepal Tourism Board. Everest Base Camp. Supports the Nepal-side trekking context, Khumbu Glacier setting and final glacier-terrain approach beyond Gorak Shep. The simulator retains 5,364 m from its approved environmental reference table. Tourism board location description
Tourism board location description

[G9] Nepal National Mountain Guide Association. Mount Everest. Supports the highest-summit fact, Nepal–China border, 8,849-m elevation and summit coordinates 27°59′17″ N, 86°55′31″ E; rounded to 27.988° N, 86.925° E on the card. Everest mountain profile
Everest mountain profile

Card mapping: Sea level—P2/P4; Calgary—P1/P2/G1/G2; Columbia—P1/P2/G1/G3; Pheriche—P1/P2/G5/G7, with G6 documenting elevation context; EBC—P1/P2/G7/G8; Logan—P3/G1/G3/G4; Everest—P3/G9. “Why here” lines express the instructor’s teaching purpose. No geographic coordinate changes the pressure model.

Coordinates are approximate place context, not physiological sampling locations. Pheriche retains the approved 4,300-m model input, distinct from clinic/weather-station elevations. No geographic coordinate changes model PB.

Extreme-altitude extension · v1.1

Extreme references combine specified human study anchors with the model atmosphere and equations. They represent selected acclimatized lowlanders sampled under stated conditions, not acute arrival, a safe exposure, or an indefinitely sustainable state.

Acid–base effect on Hb affinity, with temperature and BPG fixed. The curve does not predict the complete blood-affinity response to extreme-altitude acclimatization. Arterial saturation is not estimated for this extreme reference.

Calculated alveolar PO₂ with the reference CO₂ held fixed. Ventilatory and arterial responses to oxygen are not modeled here.

Mount Logan · source and value provenance

Acid–base reference from a nearby ~6,000 m hypobaric-chamber condition. CO₂ uses an arterialized-capillary surrogate; this is not a direct Mount Logan summit physiological measurement.

logan_oeiii_6000_acidbase_v1 · R2, R3

7 days at 4350 m then progressive chamber exposure; measurements after 2 days at each stage. arterialized ear capillary; n=8. 1 h before muscle protocols; exact quiet-rest and last-O2 intervals not reported in retrieved evidence. R2 Table 1 and methods p.331; R3 companion protocol

Source PB 370 mmHg: R3 companion protocol context, not attached to each R2 blood draw; never used as model PB.

Stored CO₂ / HCO₃⁻: 20.0 mmHg / 15.422374696613188 mmol/L. Bicarbonate is model-derived from source mean CO₂ and pH; pH is then calculated centrally.

Original source observations and sampling details
{
  "study": "Operation Everest III",
  "nominalAltitude_m": 6000,
  "actualPressure_mmHg": 370,
  "pressureStatus": "R3 companion protocol context, not attached to each R2 blood draw; never used as model PB",
  "inspiredGas": "hypobaric chamber air",
  "sample": "arterialized ear capillary",
  "n": 8,
  "population": "selected male lowlanders",
  "exposure": "7 days at 4350 m then progressive chamber exposure; measurements after 2 days at each stage",
  "sampling": "1 h before muscle protocols; exact quiet-rest and last-O2 intervals not reported in retrieved evidence",
  "locator": "R2 Table 1 and methods p.331; R3 companion protocol",
  "observations": {
    "PCO2": {
      "mean": 20,
      "SEM": 1,
      "status": "measured arterialized-capillary surrogate"
    },
    "pH": {
      "mean": 7.51,
      "SEM": 0.01,
      "status": "measured"
    },
    "capillaryPO2": {
      "mean": 49,
      "SEM": 1,
      "status": "measured; NOT adopted as model PaO2"
    },
    "HCO3": {
      "value": null,
      "status": "not reported"
    }
  },
  "temperature": "blood-gas correction not established from extracted methods; model separately fixes 37°C"
}
Everest summit · source and value provenance

Resting summit-equivalent chamber reference in acclimatized lowlanders. Arterial PO₂ is derived using the approved effective model assumptions; it is not a field summit arterial measurement.

everest_oeii_rest_v1 · R4

approximately 40-day chamber campaign; final PB 282 to 240 ramp over 20–30 min with catheters in place. radial/brachial arterial; 0 W resting column; n=6. exact intervals since preceding exercise/O2 and duration of summit-condition rest not reported; not prolonged summit residence. R4 Tables 3–6 pp.1313–1314, methods pp.1310–1311; resting 0 W Table 6

Source PB 240 mmHg: source condition only; never used as model PB.

Stored CO₂ / HCO₃⁻: 11.2 mmHg / 9.690345850505395 mmol/L. Bicarbonate is model-derived from source mean CO₂ and pH; pH is then calculated centrally.

Original source observations and sampling details
{
  "study": "Operation Everest II",
  "nominalCondition": "summit-equivalent chamber; PIO2 labelled 43 mmHg",
  "actualPressure_mmHg": 240,
  "pressureStatus": "source condition only; never used as model PB",
  "FiO2_approx": 0.22,
  "PIO2_approx_mmHg": 42.5,
  "sample": "radial/brachial arterial; 0 W resting column",
  "n": 6,
  "participantsAtStart": 8,
  "population": "selected male acclimatized lowlanders",
  "exposure": "approximately 40-day chamber campaign; final PB 282 to 240 ramp over 20–30 min with catheters in place",
  "sampling": "exact intervals since preceding exercise/O2 and duration of summit-condition rest not reported; not prolonged summit residence",
  "locator": "R4 Tables 3–6 pp.1313–1314, methods pp.1310–1311; resting 0 W Table 6",
  "observations": {
    "PaCO2": {
      "mean": 11.2,
      "SD": 1.7,
      "status": "measured arterial"
    },
    "pH": {
      "mean": 7.56,
      "SD": 0.03,
      "status": "measured"
    },
    "HCO3": {
      "mean": 9.92,
      "SD": 1.04,
      "status": "source calculated; retained separately, not model input"
    },
    "PaO2": {
      "mean": 30.3,
      "SD": 2.1,
      "status": "measured arterial; not direct model output"
    },
    "SaO2": {
      "mean": 58,
      "SD": 4.5,
      "status": "reported; exact table-column method not isolated; not used as model output"
    },
    "Aa": {
      "mean": 1.5,
      "SD": 1,
      "status": "source calculated; transferred as effective model assumption for air only"
    }
  },
  "temperature": "body temperature measured during catheter studies; chamber room 18–22°C; model separately fixes 37°C"
}
Model decisions and evidence status
  • No extension of Arrival/Developing/Established, no physiological interpolation, no context-marker physiology.
  • One continuous reference atmosphere; source PB retained for provenance only.
  • Logan CO2: measured arterialized-capillary observation transferred as an arterial surrogate. Everest CO2: measured resting arterial observation transferred from the selected chamber condition.
  • Stored bicarbonate is inverse-HH model-derived from source mean CO2 and pH, not a directly measured value or mean of individual calculations. Model pH is recomputed centrally.
  • Alveolar PO2 is equation-derived with R=0.80, PH2O=47, FiO2=0.2093 or 1.00.
  • Logan has no arterial correction. Everest air-only 1.5-mmHg effective correction is an assumption; PaO2 is approximate/model-derived, not a measured field summit output.
  • All extreme SaO2 and arterial Hb markers are deliberately unavailable even when PaO2 exists.
  • DKB paper2016 P50/curve is a theoretical acid-base component at fixed T=37 and BPG=.00465; no BPG tuning.
  • O2 is conditional fixed-reference-CO2 PAO2 only. Never apply the core 50-mmHg correction to either extreme.
  • Reference states represent selected acclimatized lowlanders under stated study conditions, not acute arrival, safe exposure or indefinite sustainability.
  • Retained Comparison freezes reference provenance and component support. Differences are not a simulated ascent.
  • Preserve the EBC Established to Logan PAO2 increase; environmental pressures still decrease.
  • Gamow remains environmental only; Diamox qualitative; illness and I5D presentation only.
Extreme-reference source register · R1–R15

[R1] Sutton JR, Bryan AC, Gray GW, Horton ES, Rebuck AS, Woodley W, Rennie ID, Houston CS. Pulmonary gas exchange in acute mountain sickness. Aviat Space Environ Med. 1976; 47(10):1032–1037. PMID: 985274. No DOI identified. Source
Audit source use: Primary abstract retrieved; no complete numerical summit tuple extracted.

[R2] Caquelard F, Burnet H, Tagliarini F, Cauchy E, Richalet JP, Jammes Y. Effects of prolonged hypobaric hypoxia on human skeletal muscle function and electromyographic events. Clin Sci. 2000; 98(3):329–337. DOI: 10.1042/cs0980329. PMID: 10677392. Source
Audit source use: Author-deposited full text inspected, especially Table 1 and methods p. 331. Some metadata indexes 10.1042/CS19990263; title, journal, pages and PMID identify the same paper.

[R3] Robach P, Déchaux M, Jarrot S, Vaysse J, Schneider JC, Mason NP, Herry JP, Gardette B, Richalet JP. Operation Everest III: role of plasma volume expansion on V̇O₂max during prolonged high-altitude exposure. J Appl Physiol. 2000; 89(1):29–37. DOI: 10.1152/jappl.2000.89.1.29. PMID: 10904032. Source
Audit source use: Primary abstract/publisher metadata used for 370-mmHg chamber context, not blood-gas calibration.

[R4] Sutton JR, Reeves JT, Wagner PD, Groves BM, Cymerman A, Malconian MK, Rock PB, Young PM, Walter SD, Houston CS. Operation Everest II: oxygen transport during exercise at extreme simulated altitude. J Appl Physiol. 1988; 64(4):1309–1321. DOI: 10.1152/jappl.1988.64.4.1309. PMID: 3132445. Source
Audit source use: Full primary paper inspected; Tables 3–6, pp. 1313–1314 and methods pp. 1310–1311. Table 6 inspected visually.

[R5] West JB, Hackett PH, Maret KH, Milledge JS, Peters RM Jr, Pizzo CJ, Winslow RM. Pulmonary gas exchange on the summit of Mount Everest. J Appl Physiol Respir Environ Exerc Physiol. 1983; 55(3):678–687. DOI: 10.1152/jappl.1983.55.3.678. PMID: 6415007. Source
Audit source use: Author-deposited primary article; summit gas discussion and Tables 2, 4, 5. Actual alveolar samples are separated from inferred arterial outputs.

[R6] Grocott MPW, Martin DS, Levett DZH, McMorrow R, Windsor J, Montgomery HE; Caudwell Xtreme Everest Research Group. Arterial blood gases and oxygen content in climbers on Mount Everest. N Engl J Med. 2009; 360(2):140–149. DOI: 10.1056/NEJMoa0801581. PMID: 19129527. Source
Audit source use: Author-deposited primary article; Figure 1, arterial-gas text p. 144 and Table 2 p. 145. Source saturation and bicarbonate are calculated.

[R7] Richalet JP, Robach P, Jarrot S, Schneider JC, Mason NP, Cauchy E, Herry JP, Bienvenu A, Gardette B, Gortan C. Operation Everest III (COMEX97): effects of prolonged and progressive hypoxia on humans during a simulated ascent to 8848 m in a hypobaric chamber. Adv Exp Med Biol. 1999; 474:297–317. DOI: 10.1007/978-1-4615-4711-2_23. PMID: 10635009. Source
Audit source use: Primary chapter abstract retrieved. Full chapter restricted; absent methods are not inferred. Sample explicitly arterialized capillary.

[R8] Malconian MK, Rock PB, Reeves JT, Cymerman A, Houston CS. Operation Everest II: gas tensions in expired air and arterial blood at extreme altitude. Aviat Space Environ Med. 1993; 64(1):37–42. PMID: 8424738. No DOI identified. Source
Audit source use: Primary abstract and initially accessible publisher PDF checked; later PDF access intermittent. Overlapping OE II observations; pooled A–a not used as summit calibration.

[R9] Samaja M, Mariani C, Prestini A, Cerretelli P. Acid-base balance and O₂ transport at high altitude. Acta Physiol Scand. 1997; 159(3):249–256. DOI: 10.1046/j.1365-201X.1997.574342000.x. PMID: 9079156. Source
Audit source use: Primary full text and Table 1 p. 252 inspected. Source 6450-m pressure discrepancy retained; capillary gases and pulse saturation distinguished.

[R10] Winslow RM, Samaja M, West JB. Red cell function at extreme altitude on Mount Everest. J Appl Physiol. 1984; 56(1):109–116. DOI: 10.1152/jappl.1984.56.1.109. PMID: 6693310. Source
Audit source use: University-deposited primary PDF inspected; Table 5 p. 113 and assay methods. Summit affinity inferred; BPG uses molar ratio to Hb.

[R11] Wagner PD, Wagner HE, Groves BM, Cymerman A, Houston CS. Hemoglobin P50 during a simulated ascent of Mt. Everest, Operation Everest II. High Alt Med Biol. 2007; 8(1):32–42. DOI: 10.1089/ham.2006.1049. PMID: 17394415. Source
Audit source use: Primary abstract retrieved; full text unavailable. Same expedition as R4/R8; concentration compartment not resolved from abstract.

[R12] Dash RK, Korman B, Bassingthwaighte JB. Simple accurate mathematical models of blood HbO₂ and HbCO₂ dissociation curves at varied physiological conditions—evaluation and comparison with other models. Eur J Appl Physiol. 2016; 116(1):97–113. DOI: 10.1007/s00421-015-3228-3. PMID: 26298270; PMCID: PMC4699875. Source
Audit source use: Full paper, equations 8–11, Table 1 and Figures 3–4 inspected; paper2016 retained, not archive2017.

[R13] Schoene RB, Roach RC, Hackett PH, Sutton JR, Cymerman A, Houston CS. Operation Everest II: ventilatory adaptation during gradual decompression to extreme altitude. Med Sci Sports Exerc. 1990; 22(6):804–810. DOI: 10.1249/00005768-199012000-00012. PMID: 2287258. Source
Audit source use: Primary abstract retrieved; oxygen-response duration and arterial gas changes not supplied by that abstract.

[R14] Woyke S, Oberacher H, Plunser D, et al. A new approach to haemoglobin oxygen affinity research at high altitude: determination of haemoglobin oxygen dissociation curves and 2,3-bisphosphoglycerate in an experimental human crossover hypoxic chamber study. Eur J Appl Physiol. 2025; 125:2979–2984. DOI: 10.1007/s00421-025-05806-1. PMID: 40314729; PMCID: PMC12479569. Source
Audit source use: Primary article inspected for methods context at 3500 m; no extreme-state numerical anchor taken.

[R15] Wakeham DJ, Tomlinson AR, Manferdelli G, et al. The physiological and altitude lowering effects of different supplemental oxygen flow rates at extreme simulated altitude: a pilot study. High Alt Med Biol. 2026; 27(3):143–151. DOI: 10.1177/15578682251396453. PMID: 41468173. Source
Audit source use: Primary abstract and supplied I5D source record; unacclimatized mask-flow/SpO₂ study, not the selected arterial-gas reference.

Audit evidence and modeling-decision record
3 Literature review method and evidence rules
Literature-review record retained from v1.0. No new literature search was performed for this synchronization.
Searches conducted on 8 October 2026 covered direct Mount Logan research, resting lowlander blood gases around 5200–6500 m, AMREE, Caudwell Xtreme Everest, Operation Everest II and III, extreme-altitude P50/BPG, and oxygen-breathing responses. Primary papers, publisher abstracts and author-deposited full texts were prioritized. This is a critical model audit with targeted citation follow-up, not a registered systematic review or a claim that every relevant publication has been found.
Each study is first interpreted at its own pressure, inspired gas, sampling site and exposure protocol. Transfer into the reference atmosphere is a separate modeling decision. The evidence tables distinguish original observations from calculated source outputs and from this audit’s model calculations. NR means not reported in the material retrieved; it does not mean zero. A chapter or abstract-only result cannot supply methods absent from that retrieved text.
Publications within each expedition may share participants and must not be counted as independent replications. OE II, OE III, AMREE and Caudwell remain distinct evidence families. Rest refers to the sampling condition and does not establish indefinite physiological stability. Recent exercise, oxygen withdrawal, selection, attrition and sampling constraints remain part of interpretation. No individual confidence interval is inferred from a reported group SD, SEM, a diagnostic sensitivity range or rounded means.
4 Evidence landscape
The following linked tables form the extraction record. Source IDs connect protocol, numerical and affinity information without forcing more than twenty columns onto one page. All numerical anchors are from primary studies; source locations and retrieval limits are stated in the reference register.
ID and setting | Population and exposure | Sampling and gas context | Use
R1 Logan field
5360 m | Healthy volunteers rapidly airlifted from 2990 m; all developed AMS; n NR in abstract. | Blood-gas study; exact PB, gas timing and individual values not retrieved. | Direct Logan research exists, but this is neither the 5959 m summit nor the selected healthy acclimatized reference.
R2 OE III
5000 to 7000 m | Eight male lowlanders; 7 days at 4350 m, then progressive chamber exposure. | Arterialized ear capillary samples 1 h before muscle protocols; measurements after 2 days at each stage. Exact quiet-rest and last-O₂ intervals NR. | 6000 m acid–base analogue; capillary O₂ not adopted as arterial O₂.
R3 OE III
6000 m | Companion protocol from the same exposure campaign. | PB 370 mmHg reported; not a PB measurement attached to each R2 blood draw. | Pressure-context corroboration only.
R4 OE II
PIO₂ 80, 63, 49, 43 | Eight men began; summit resting arterial n=6. Approximately 40-day chamber campaign; final PB 282 → 240 ramp over 20–30 min with catheters in place. | Radial/brachial arterial sampling at 0 W. Final FiO₂ about 0.22. Exact intervals since earlier exercise/O₂ and duration of summit-condition rest NR. | Selected Everest arterial dataset; rest does not establish prolonged summit-equivalent residence.
R5 AMREE
actual summit | One climber; four valid summit alveolar samples after at least 10 min without climbing O₂. | PB 253; alveolar gas, not arterial summit blood. Subsequent South Col venous/base-excess information used for inference. | Field constraint; inferred arterial values remain distinct.
R6 Caudwell
5300 to 8400 m | Selected expedition climbers; highest arterial n=4 after 60 days above 2500 m. | At 8400 m, 20 min resting off O₂ during descent; femoral samples cooled and analyzed within 2 h; 37°C assumed. | Independent field context; no summit relabelling.
R7 OE III
summit equivalent | Eight male volunteers; summit capillary n=5. Vallot preacclimatization and 31 chamber days. | PB 253; arterialized capillary blood. Full chapter unavailable; detailed timing NR. | Chamber corroboration independent of OE II; overlaps the R2/R3 expedition family.
R8 OE II
PIO₂ 55 to 43 | Six men; overlapping OE II cohort. | Paired expired-gas/arterial observations; pooled A–a across 27 pairs, not a summit-only gradient. | Method and small-gradient context; do not mix sessions with R4.
R9 Himalayan field
5050 and 6450 m | Lowlanders; 6450 m n=11, 1–3 days at Camp II after prior altitude exposure. | Arterialized ear capillary gases and pulse oximetry; reported pressure at 6450 m is discrepant with the model atmosphere. | Alternative acid–base context; no exact pressure-transferred arterial anchor.

4.1 Extracted blood gas observations
M = directly measured gas/pH; C = calculated by the source; AC = arterialized capillary, retained as a surrogate; Rpt = reported saturation with the exact table-column method not isolated. Dashes denote NR, not unavailable source physiology. Dispersion is SD for R4, SEM for R2/R9, and as reported for R7. Units: pressure mmHg, HCO₃⁻ mmol/L, saturation percent. [R1–R9]
Source condition | PB | CO₂ | pH | HCO₃⁻ | O₂ in blood | Saturation | A–a
R1 Logan 5360 | NR | NR | NR | NR | NR | NR | NR
R2 5000 m n=8 | NR | 24 ±1 AC | 7.47 ±.01 M | NR | 53 ±1 AC | NR | NR
R2 6000 m n=8 | ≈370¹ | 20 ±1 AC | 7.51 ±.01 M | NR | 49 ±1 AC | NR | NR
R2 7000 m n=8 | NR | 18 ±1 AC | 7.49 ±.01 M | NR | 40 ±2 AC | NR | NR
R4 PIO₂ 80 n=8 | 428 | 25.0 ±2.2 M | 7.46 ±.02 M | NR | 52.4 ±4.0 M | 84.8 ±4.0 Rpt | −2.3 ±2.9 C
R4 PIO₂ 63 n=7 | 347 | 20.0 ±2.8 M | 7.50 ±.04 M | 15.49 ±1.23 C | 41.1 ±3.3 M | 75.2 ±6.0 Rpt | −0.1 ±2.4 C
R4 PIO₂ 49 n=5 | 282 | 12.5 ±1.1 M | 7.53 ±.03 M | 10.56 ±.70 C | 36.6 ±2.2 M | 67.8 ±5.0 Rpt | 1.6 ±1.3 C
R4 PIO₂ 43 n=6 | 240² | 11.2 ±1.7 M | 7.56 ±.03 M | 9.92 ±1.04 C | 30.3 ±2.1 M | 58.0 ±4.5 Rpt | 1.5 ±1.0 C
R5 actual summit n=1 | 253 | 7.5 alveolar M | >7.7 inferred | Inferred | ≈28 inferred | ≈70 inferred | Model-dependent
R6 5300 m | 403.5 | 20.4 M | 7.46 M³ | NR | Figure only⁴ | Mixed C/pulse³ | NR
R6 6400 m | 350 | 18.2 M | 7.51 M | NR | Figure only⁴ | Calculated | NR
R6 8400 m n=4 | 272 | 13.3 M | 7.53 M | 10.8 C | 24.6 M | 54.0 C | 5.41 C
R7 summit n=5 | 253 | 11.9 ±1.4 AC | 7.58 ±.02 M | NR | 30.6 ±1.4 AC | NR | NR
R8 summit n=6 | Session-specific | 11.4 ±1.6 M | 7.53 M | NR | NR | NR | −0.8 ±2.4 pooled⁵
R9 5050 m n=20 | 425 reported | 23.9 ±.5 AC | 7.474 ±.005 M | NR | 43.7 ±.9 AC | Pulse context | NR
R9 5050 later n=8 | 425 reported | 21.0 ±1.0 AC | 7.478 ±.011 M | NR | 43.5 ±1.1 AC | Pulse context | NR
R9 6450 m n=11 | 308 reported⁶ | 18.7 ±.5 AC | 7.496 ±.006 M | NR | 33.6 ±1.1 AC | 73.4 ±3.0 pulse | NR

¹ Companion R3 protocol pressure, not an individual draw measurement. ² FiO₂ approximately 0.22; PIO₂ approximately 42.5, labelled 43. ³ Four of nine EBC pH measurements failed; oxygen saturation was replaced by pulse values in those cases. Marginal means do not guarantee matching participants. ⁴ Lower-altitude arterial PO₂ was plotted, not adopted here as an exact digitized anchor. ⁵ R8 pooled 27 observations across PIO₂ 55–43; not a summit gradient. ⁶ R9 prints 308 mmHg at 6450 m; this discrepancy is retained, not silently repaired. [R3–R9]
R4 used co-oximetry, content measurements and analyzer calculations to check saturation, but its table does not isolate the technique supplying each SaO₂ entry. R6 explicitly calculated saturation and bicarbonate and used an R measured at a different altitude when deriving A–a. Neither table should be described casually as independent co-oximetry validation of this model. [R4, R6]
4.2 Affinity and oxygen response evidence
Source | Observation or method | Meaning for this audit
R10 AMREE red cells | In-vivo P50: 27.6 at 6300 m, 24.9 at 8050 m (n=2), 19.4 at summit (n=1, inferred chemistry). DPG reported as mol DPG per mol Hb. | Different measurement and inference conditions from OE II; no universal summit P50 or transferable BPG concentration.
R11 OE II affinity | Five subjects; standard P50 28.2 → 33.1; in-vivo P50 remained 26–27. Reported BPG 1.7 → 3.8 mmol/L; compartment unresolved in abstract. | Same expedition, not independent replication. Demonstrates counteracting net affinity influences.
R12 DKB paper2016 | Wide model simulation sweeps; selected experimental fits include plasma-pH/PCO₂ pairs 7.50/15, 7.25/40 and 7.15/70. | Successful computation at extreme inputs is not joint empirical validation of those inputs.
R13 OE II oxygen breathing | At PB 305, oxygen reduced resting ventilation by 9.6 ±1.3 L/min in seven men. | Fixed CO₂ during an oxygen comparison is a controlled model assumption, not a measured oxygen-response trajectory.
R14 2025 affinity methods | Moderate-altitude 3500 m study measured BPG and affinity using individual gas conditions; not an extreme-altitude calibration. | Independent methodological context for separating actual-condition from standardized affinity.
R15 2026 mask study | Six unacclimatized volunteers; PB 282 and 253; mask gas fraction and SpO₂ during four-minute flow conditions. | Modern oxygen-device evidence does not supply an acclimatized 100 percent O₂ arterial correction.

4.3 Inspired gas, alveolar oxygen and temperature
Source condition | Inspired gas and PAO₂ evidence | Temperature and transfer limits
R2 OE III 6000 m | Hypobaric chamber air; no directly measured PAO₂ extracted. Model calculation at companion PB 370 and PCO₂ 20 is 43.6504 under the retained assumptions. | Blood-gas temperature correction was not established from the extracted methods; the model independently fixes 37°C.
R4 OE II summit | Hypobaric chamber FiO₂ about 0.22 at PB 240; PIO₂ about 42.5. A–a is calculated. PaO₂ + A–a from reported means is 31.8; that sum is this audit’s reconstruction, not a directly sampled alveolar measurement. | Body temperature was measured during catheter studies. Chamber room temperature was 18–22°C. Preserve the teaching model’s separate 37°C assumption.
R5 AMREE summit | Field ambient air at PB 253 after O₂ withdrawal. Measured alveolar PO₂ 37.6; authors used approximately 35 with assumed R 0.85 for their resting interpretation. | Summit arterial chemistry and affinity were inferred; subsequent blood sampling cannot establish directly measured summit temperature or pH.
R6 Caudwell 8400 m | Field ambient air at PB 272; PIO₂ about 47. Reported calculated PAO₂ mean 30.0; individual values 32.4, 26.9, 27.4 and 33.2. R was measured at 7950 m and imputed for one subject. | Samples analyzed at 37°C; the same body temperature was assumed. This is a source convention, not a measured temperature in every summit climber.
R1 / R7 / R8 / R9 | Field or hypobaric-chamber exposures as listed above; unlisted gas/PAO₂ details are NR in the extracted record. | No temperature correction is imported where the retrieved evidence does not establish it.

Both selected analogue sources used reduced pressure. Normobaric hypoxia instead lowers oxygen fraction at approximately ambient pressure; the two exposure methods are not declared physiologically interchangeable by matching inspired PO₂ alone. No normobaric result calibrates either proposed state. Field studies carry greater weight for mountain context, but their exercise, oxygen use, weather and sample transport make them less controlled resting model anchors. The chamber references offer controlled measurements while retaining a clear limit on transfer to climbers. [R2, R4–R7]
Selection and survivorship further restrict the intended population. These small samples consist of people who entered demanding protocols and remained available for measurement. Attrition at later stages and successful mountain ascent select the observed participants; neither study means nor the simulator reference estimate the response of an unselected person suddenly exposed to the summit. “Selected acclimatized lowlanders” is therefore more defensible than “typical adult at Everest.” [R4–R7]
5 Mount Logan evidence and reference choice
Direct Mount Logan physiology research was found. It does not provide a retrieved healthy, extensively acclimatized arterial tuple at the current 5959 m summit landmark. The R1 study concerns rapid exposure at 5360 m with AMS; its name alone does not establish a summit reference. [R1]
The preferred analogue is the R2 6000 m hypobaric-chamber acid–base condition. Its same-condition eight-person CO₂/pH means, together with the nearby pressure reported by the companion protocol, provide a cleaner reference construction than combining different studies or unmatched EBC marginal means. This is an analogue transfer, not interpolation or a direct measurement at Mount Logan. Its proximity justifies a representative teaching input; it does not establish identical physiology between the chamber and the Yukon summit. [R2–R3]
Retain PCO₂ = 20.0 and measured mean pH = 7.51 as source anchors. Use the capillary CO₂ as the model’s arterial surrogate and derive HCO₃⁻ with the locked Henderson–Hasselbalch convention. Do not import the source capillary PO₂ = 49 as arterial PaO₂: even at the companion PB 370, the model’s R 0.80 equation gives PAO₂ 43.6504. The mismatch is a source/model and sampling issue, not a reason to change the source or tune the model. [R2–R3; C2]
5.1 Alternatives considered
Alternative | Construction and finding | Decision
Caudwell field interpolation | Pressure fraction (403.5−371.344341)/(403.5−350)=0.601040353. Derive endpoint HCO₃⁻ from 20.4/7.46 and 18.2/7.51, interpolate CO₂ and HCO₃⁻, then calculate pH. Result: CO₂ 19.077711; HCO₃⁻ 14.028675; pH 7.489369; PAO₂ 45.036373. | Scientifically transparent alternative, but different sample availability and exposure dates; not matched individual interpolation. Not selected. [R6]
Altitude interpolation of the same field means | Fraction (5959−5300)/(6400−5300)=0.599090909 gives CO₂ 19.082; pH 7.489271; PAO₂ 45.031236. | Method difference is small; it does not remove biological/protocol uncertainty. Not an uncertainty interval.
OE II intermediate arterial means | R4 PIO₂ 80 and 63 bracket model PIO₂ 67.885. Acid–base interpolation is possible, but source A–a means are small/negative and participant counts differ. | Useful competing reference; no hidden clamping or automatic A–a transfer. Not selected.
Samaja field series | Nearby CO₂ and pH support the general range, but pressure, sample type, timing and cohort differ. | Context only; do not average into the selected tuple. [R9]

The selected Logan state makes no quantitative arterial oxygen or saturation claim. An oxygenation-complete Logan state would need a separately justified arterial calibration at compatible exposure and gas conditions. That missing component does not invalidate the acid–base reference.
6 Everest evidence and reference choice
Use the 0 W column of R4 Table 6 as the primary source tuple. Its simultaneous arterial gas/pH measurements and explicit resting condition make it preferable for this reduced resting model to combining summit alveolar samples with blood collected later, or relabelling the R6 8400 m observations as summit data. The reference is chamber-informed and selected, not field-measured at 8849 m. [R4–R6]
The final OE II step followed the PB 282 study: subjects were decompressed to PB 240 over 20–30 minutes with catheters in place. The 0 W column establishes rest at sampling, not prolonged residence or a fully settled physiological equilibrium at summit-equivalent pressure. Exact elapsed time since preceding exercise/O₂ exposure was not established in the extracted record. The proposed label therefore refers to selected acclimatized participants under that protocol, not “fully acclimatized to Everest.” [R4]
The source’s summit-equivalent inspired oxygen condition is approximately matched, even though actual PB and FiO₂ were not simply 253 mmHg and ambient air. Preserve the model atmosphere and R 0.80. Transfer the reported resting A–a 1.5 as an effective calibration assumption. This gives a coherent approximate PaO₂ without pretending that the source’s measured 30.3 is a direct model output. [R4; C2]
AMREE supplies authentic summit alveolar evidence, but its famous severe alkalemia and arterial oxygen values are inferred. Its measured alveolar PO₂ 37.6 was itself judged unsuitable as the resting reference by the authors; their approximately 35 value used an assumed R 0.85. R6 supplies direct 8400 m arterial evidence with different ascent, oxygen and field conditions. R7 supports the chamber acid–base range but uses capillary samples. These sources constrain interpretation; they are not averaged into a single artificial summit participant. [R5–R7]
7 Acid base and gas equation contract
Preserve the current source convention: store a PaCO₂/HCO₃⁻ pair and calculate model pH. To preserve a selected measured source pH, derive the bicarbonate input by the inverse equation. A model constructed from group means is not the mean of individually calculated states. Source-reported mean bicarbonate remains unchanged in the evidence table. [C1–C2]
H = altitude in metres / 1000
PB = exp(6.63268 − 0.1112H − 0.00149H²)
Dry PO₂ = FiO₂ × PB
PIO₂ = FiO₂ × (PB − 47)
pH = 6.1 + log₁₀[HCO₃⁻ / (0.03 × PaCO₂)]
HCO₃⁻ = 0.03 × PaCO₂ × 10^(pH − 6.1)
PAO₂ = PIO₂ − PaCO₂ × [FiO₂ + (1 − FiO₂)/0.80]
PaO₂ = PAO₂ − effective A–a, only where that correction is supported
Use FiO₂ 0.2093 on air, 1.00 on oxygen, PH₂O 47 mmHg, R 0.80, temperature 37°C and BPG 0.00465 mol/L. With air, the CO₂ multiplier is 1.197675. With pure oxygen, PAO₂=PB −47−PaCO₂ and R cancels. These are retained model assumptions, not newly measured extreme-altitude constants. [C2]
At extreme altitude, body temperature, measured respiratory exchange ratio and recent gas exposure need not equal those fixed assumptions. The audit therefore preserves two records: original study observations and the proposed internally coherent teaching state. No literature pressure is inserted into the mountain’s reference-atmosphere equation.
8 Candidate Mount Logan numerical state
Field | Full audit value | Display | Provenance and availability
Altitude | 5959 m | 5959 m | Preserved project landmark input.
PB | 371.344341113 | 371.3 | Equation-derived reference atmosphere.
Dry PO₂ | 77.722370595 | 77.7 | Equation-derived, ambient air.
PIO₂ | 67.885270595 | 67.9 | Equation-derived, humidified air.
PaCO₂ surrogate | 20.000000000 | 20.0 | Literature-informed transfer of measured arterialized-capillary PCO₂, R2; not a Logan arterial measurement.
HCO₃⁻ | 15.422374696613 | 15.4 | Model-derived from measured capillary PCO₂ + pH; retain full input.
Model pH | 7.510000000 | 7.510 | HH-derived, deliberately preserving R2 measured group-mean pH.
PAO₂ | 43.931770595 | 43.9 | Equation-derived under fixed R 0.80.
Effective A–a | null | Unavailable | No selected quantitative arterial calibration.
PaO₂ | null | Unavailable | Unsupported in proposed Logan state.
Model P50 | 22.345556034 | 22.35 | Fixed-BPG acid–base component; not measured whole-blood P50.
SaO₂ and Hb arterial marker | null | Unavailable | No supported arterial oxygenation/saturation tuple.

Measured source dispersion is PCO₂ 20±1 mmHg and pH 7.51±0.01 SEM in eight participants. Those SEMs do not define a population range for the model reference. No joint covariance or individual bicarbonate distribution was retrieved, so no propagated individual uncertainty interval is claimed. [R2]
9 Candidate Everest summit numerical state
Field | Full audit value | Display | Provenance and availability
Altitude | 8849 m | 8849 m | Preserved project landmark input; historical papers use 8848.
PB | 252.647957275 | 252.6 | Equation-derived reference atmosphere.
Dry PO₂ | 52.879217458 | 52.9 | Equation-derived ambient air.
PIO₂ | 43.042117458 | 43.0 | Equation-derived; near R4 summit-equivalent inspired PO₂.
PaCO₂ | 11.200000000 | 11.2 | Measured arterial source anchor transferred from R4 resting group mean.
HCO₃⁻ | 9.690345850505 | 9.7 | Model-derived from measured PaCO₂ + pH; not source 9.92.
Model pH | 7.560000000 | 7.560 | HH-derived, preserving R4 measured group-mean pH.
PAO₂ | 29.628157458 | 29.6 | Equation-derived at R 0.80.
Effective A–a | 1.500000000 | 1.5 | Transferred R4 reported calculated resting difference; effective model assumption.
PaO₂ | 28.128157458 | ≈28 | Model-derived, chamber-informed estimate; not measured summit PaO₂.
Model P50 | 20.555101110 | 20.56 | Fixed-BPG acid–base component only.
SaO₂ and Hb arterial marker | null | Unavailable | Whole-blood affinity not represented adequately for this arterial-state claim.

The source group SDs are CO₂ 1.7 mmHg, pH 0.03 and PaO₂ 2.1 mmHg; they describe that small sample. The proposed effective correction is not a universal lung-efficiency constant. Its ±1 SD diagnostic variation, 0.5–2.5, gives model PaO₂ 29.13–27.13. This sensitivity is not a confidence interval and omits correlated physiological, sampling and protocol uncertainty. [R4]
9.1 Why the source and model oxygen values differ
Directly inserting 30.3 as arterial PO₂ beneath model PAO₂ 29.628 would imply A–a −0.672. The selected construction instead keeps the reported effective correction 1.5 and derives PaO₂ 28.128. The source ratio of mean VCO₂/VO₂ is 369/386≈0.956, while the model retains 0.80; this ratio is not the unpublished mean individual R. Rebuilding PAO₂ from rounded marginal means also need not recover a published mean A–a. The source observation is preserved in the evidence record. [R4; C2]
Arterial strategy | Assessment
A Literature-informed effective correction | Selected for Everest only: 1.5, with explicit chamber-transfer assumptions.
B Copy measured arterial PO₂ | Rejected as a model-state shortcut when it breaks the gas cascade. Original measurements remain evidence.
C Bounded parameter range | Used as sensitivity around the selected correction, not a physiological probability distribution.
D Withhold arterial PO₂ | Selected for Logan; its preferred acid–base source does not justify a compatible arterial calibration.
Average field and chamber gradients | Rejected. R6 field 5.41 and R4 chamber 1.5 differ in protocol, altitude, gas assessment and participants.

10 Hemoglobin affinity and saturation decision
Retain BPG 0.00465 mol/L in the locked DKB red-cell concentration parameter convention, with no additional RBC-water rescaling, and temperature 37°C. This parameter is not directly interchangeable with whole-blood BPG, a DPG/Hb molar ratio or a mass-normalized assay result. The curves answer a controlled question: how do the selected CO₂ and pH alter affinity when other modeled inputs are held fixed? The proposed P50 values do not claim to be actual whole-blood or in-vivo extreme-altitude P50. [C1–C2; R12]
The DKB paper’s broad simulation sweeps do not establish joint empirical validation throughout that space. Its illustrated empirical gas/pH fits include CO₂ 15 mmHg; the selected Everest input 11.2 is lower. This does not justify inventing a hard pH ceiling or declaring the formula mathematically invalid. It supports a narrower theoretical interpretation at Everest. [R12]
Comparison | Finding | Interpretation
R4 same-condition gas/pH means | DKB at pH 7.56, CO₂ 11.2 and measured PaO₂ 30.3 gives 74.104331%; source reports 58.0%. Difference +16.104331 percentage points. | Conditional calculation at fixed model BPG/37°C. Group aggregation and source-method limits remain; this is not an individual error estimate.
Proposed model arterial point | DKB at model PaO₂ 28.128157 gives 69.918336%. | Diagnostic only. Do not display as the extreme reference SaO₂.
R11 actual-condition affinity | In-vivo P50 remained 26–27 while standard P50 increased. | Unopposed fixed-BPG left shift does not reproduce the full net acclimatized response.
R10 historical field contrast | AMREE inferred a much lower summit in-vivo P50 in one climber. | Evidence depends on protocol and inference. It does not justify selecting whichever P50 fills the desired curve.

The entire saturation discrepancy cannot be attributed to BPG omission alone. It may also reflect baseline affinity, response coefficients, concentration conventions, measurement methods and aggregation. No parameter is tuned to erase it. Adding an extreme-only BPG input would change what cross-state curve differences mean and require a separate whole-blood model scope, matched concentration conversions and verification. That expansion is not recommended for V1. [R10–R12]
Therefore choose the fixed-BPG model with an explicit theoretical qualifier and model P50, while withholding extreme SaO₂ and the Hb arterial marker. A free curve-inspection point may still report fractional Hb occupancy at a user-chosen PO₂; label it “On this theoretical curve.” It must never be auto-positioned at extreme PaO₂ or labelled the current arterial state.
11 Oxygen challenge at extreme references
Permit the environmental oxygen comparison and conditional PAO₂. Preserve the reference acid–base inputs by definition, with a visible explanation that the oxygen calculation holds CO₂ fixed. The observed oxygen-driven change in ventilation in R13 shows why this is a controlled equation comparison rather than a real oxygen-treatment response. No extreme hyperoxic PaO₂ or SaO₂ calibration is adopted. [R13; C2, C7]
These are conditional gas-equation values. Oxygen wash-in, washout and the time to a new ventilatory equilibrium are not modeled; exact Air → O₂ → Air restoration describes application state.
Pure oxygen quantity | Mount Logan | Everest summit
PB and dry PO₂ | 371.344341 | 252.647957
Humidified PIO₂ | 324.344341 | 205.647957
Conditional PAO₂ | 304.344341 | 194.447957
PaCO₂ / HCO₃⁻ / pH | Reference inputs held fixed | Reference inputs held fixed
P50 and theoretical curve | Unchanged by definition | Unchanged by definition
Hyperoxic effective correction | null | null
Hyperoxic PaO₂ / SaO₂ / marker | Unavailable | Unavailable

Do not apply the existing 50-mmHg correction above EBC. It has no new extreme-altitude validation in this audit. Oxygen-device flow experiments do not make FiO₂ 1.00 a realistic mask setting; they remain context for the existing idealization. Air→O₂→Air must restore the exact air snapshot, including Everest’s air-only approximate PaO₂ and both references’ unavailable SaO₂. [C2, C7; R15]
12 Availability by view and gas
Output or component | Logan air | Logan O₂ | Everest air | Everest O₂
PB / dry PO₂ / PIO₂ | Equation | Equation | Equation | Equation
CO₂ / HCO₃⁻ / pH | Reference | Held reference | Reference | Held reference
PAO₂ | Equation | Conditional | Equation | Conditional
PaO₂ | Unavailable | Unavailable | Approximate model | Unavailable
Davenport point | Available | Same point | Available | Same point
Fixed-BPG Hb curve / P50 | Theoretical | Same curve | Theoretical | Same curve
SaO₂ / Hb arterial marker | Unavailable | Unavailable | Unavailable | Unavailable
Free Hb curve inspection | Theoretical only | Theoretical only | Theoretical only | Theoretical only
Gamow physiology | Unavailable | Existing O₂ exclusion | Unavailable | Existing O₂ exclusion

Unavailable means null, never zero, stale, inherited from Calgary, or silently calculated through a generic supported-physiology flag. The scalar arterial pressure can be available in the Inspired O₂ cascade while the Hb arterial saturation marker is unavailable. Comparison is projected component by component under the same policy.
13 Consistency with EBC Established
Quantity | EBC Established | Logan extreme | Everest extreme
PB | 400.748 | 371.344 | 252.648
PIO₂ | 74.039 | 67.885 | 43.042
PaCO₂ / surrogate | 26.1 | 20.0 | 11.2
HCO₃⁻ | 18.4 | 15.422 | 9.690
pH | 7.471 | 7.510 | 7.560
PAO₂ | 42.780 | 43.932 | 29.628
PaO₂ | 36.780 | Unavailable | 28.128 approximate
SaO₂ | 76.962% | Unavailable | Unavailable
Fixed-BPG P50 | 23.735 | 22.346 | 20.555

Environmental pressures, CO₂ and bicarbonate fall across these selected references; pH becomes more alkaline and fixed-BPG P50 falls. PAO₂ rises 1.151684 mmHg from EBC to Logan. The fall in PIO₂ is 6.154134, while the lower CO₂ reduces the modeled CO₂ subtraction by 7.305818. This accounts exactly for the non-monotonic PAO₂ result. [C2; calculations in this audit]
That change is chiefly a difference between the selected physiological reference protocols, not evidence that raising the same person by 595 m improves oxygenation. EBC Established and the chamber analogue have different exposure histories. Do not retune either state to force monotonicity. Comparisons crossing this boundary must disclose the change of reference basis; the generic model must not describe their difference as acclimatization over time. The missing Logan arterial values also mean no continuous PaO₂ or saturation sequence has been established.
The environmental causal story therefore remains continuous and monotonic: higher elevation gives lower environmental oxygen pressure at the same gas setting. The lower PaCO₂ of the separate Logan source state explains its small PAO₂ increase; it does not show that moving the same person higher improves oxygenation. Continuous environmental geometry and frozen physiological state comparison are distinct model meanings. [C9–C10]
14 State and control semantics
The instructor-approved state class is Extreme-altitude reference at Mount Logan · 5,959 m and Everest summit · 8,849 m. Keep the source-specific subtype in metadata: Logan near 6000 m chamber analogue; Everest summit-equivalent chamber reference. In the acclimatization-control location, show one read-only state with the label “EXTREME-ALTITUDE REFERENCE” and the supporting line “Based on studies of acclimatized lowlanders at extreme altitude.” Arrival, Developing and Established are not active categories at either extreme landmark; do not show three disabled choices. Detailed provenance remains available through assumptions and references. [C9–C10]
Transition | Required result
EBC Established → Logan | Select Logan reference; category becomes not applicable. Preserve gas, view and frozen Comparison.
EBC Arrival → Logan | Exactly the same Logan reference for the same gas; no residual Arrival physiology.
Logan → Everest | Select the distinct Everest source tuple and its per-output support.
Everest → EBC | EBC Arrival by deterministic default. No exposure-history inference and no remembered category introduced by this extension.
Calgary → Everest | Everest reference directly; no artificial acute-arrival physiology.
Extreme → other calibrated high altitude | Arrival by default. Existing category-preserving behavior between calibrated high-altitude locations remains.
Retained Comparison → current extreme selection | Comparison remains unchanged. The current state switches; the comparison is not a travel record or a restore action.
Air → O₂ → Air | Exact reference restoration; no accumulating oxygen exposure.
Global Reset | Calgary / Low-altitude reference / Air / Inspired O₂; clear Comparison and existing intervention/presentation state.

These deterministic rules are retained from v1.0. The proposed extension changes only the environmental-only physiological support restrictions for the two extreme landmarks. Sea level, 8000 m and contextual landmarks retain their existing support. No physiological interpolation surface, travel duration, illness risk or expedition history is added. The continuous environmental reference atmosphere is preserved. [C9–C10]
15 Comparison graph behavior and evidence encoding
An extreme reference may be saved as the normal single retained Comparison. Freeze its numerical inputs and outputs, gas, reference class/subtype, per-output availability, sample/provenance descriptions, model version, constants and theoretical-affinity flag. Future calculations or source revisions must not silently alter the retained snapshot.
Use the concise comparison safeguard: “Extreme references come from different studies, so comparisons are not a simulated ascent.” The mountain’s continuous environmental axis does not turn the retained study-based references into one person’s physiological ascent. [C9]
In Davenport, retain the immutable Calgary reference. Use a labelled open marker for the extreme source class and preserve current/comparison identity through the existing color and line conventions. A comparison-to-current arrow describes a net difference only when both points exist and differ; crossing reference types is not a within-person trajectory. The graph must include pH 7.560 and HCO₃⁻ 9.690346 with readable margins and no clipping. Existing isopleth chemistry remains authoritative.
In the Hb view, central scientific output supplies the curves. Extreme curves and P50 labels carry the fixed-BPG theoretical qualifier; no extreme arterial marker is generated. A valid calibrated comparison may retain its own arterial marker. Coincident curves are merged only when all affinity inputs match. In Inspired O₂, show each available cascade quantity and a short explanation at the first unavailable arterial step. O₂ comparisons must distinguish equation-derived alveolar pressure from unavailable arterial response.
Use the restrained badge EXTREME-ALTITUDE REFERENCE, an open marker, and an accessible source/provenance label. Keep evidence class separate from current/comparison identity and from output uncertainty. The distinction is a different evidence basis, not low-quality data. Retain the absence of red warning styling and avoid the vague description “less accurate.” [C9]
16 Student facing copy and detailed provenance
Placement | Approved wording and retained provenance
Logan state | Mount Logan · 5,959 m · Extreme-altitude reference
Logan detailed provenance | Acid–base reference from a nearby ~6,000 m hypobaric-chamber condition. CO₂ uses an arterialized-capillary surrogate; this is not a direct Mount Logan summit physiological measurement. Sources R2–R3.
Everest state | Everest summit · 8,849 m · Extreme-altitude reference
Everest detailed provenance | Resting summit-equivalent chamber reference in acclimatized lowlanders. Arterial PO₂ is derived using the approved effective model assumptions; it is not a field summit arterial measurement. Source R4; source conditions and sampling limitations remain in the detailed record.
Primary supporting line | Based on studies of acclimatized lowlanders at extreme altitude.
Across-class comparison | Extreme references come from different studies, so comparisons are not a simulated ascent.
Hb qualifier | Acid–base effect on Hb affinity, with temperature and BPG fixed. The curve does not predict the complete blood-affinity response to extreme-altitude acclimatization.
Missing saturation | Arterial saturation is not estimated for this extreme reference.
O₂ qualifier | Calculated alveolar PO₂ with the reference CO₂ held fixed. Ventilatory and arterial responses to oxygen are not modeled here.
Logan oxygenation gap | Arterial oxygenation is not calibrated for this reference.
Theory inspector | On this theoretical curve
Model assumptions | Extreme references combine specified human study anchors with the model atmosphere and equations. They represent selected acclimatized lowlanders sampled under stated conditions, not acute arrival, a safe exposure, or an indefinitely sustainable state.
Primary state label | EXTREME-ALTITUDE REFERENCE
Reference atmosphere | Reference atmosphere: This simulator uses one continuous pressure–altitude relationship across the schematic mountain. Real pressure at the same elevation varies with latitude, season, temperature and weather. Named landmarks provide elevation context, not exact local atmospheric conditions.
Detailed reference qualifier | Literature-informed physiology from selected acclimatized lowlanders; separate from the Arrival → Established grid.

The primary state label, supporting line and comparison safeguard above are instructor-approved wording. The source-specific detail and reference-atmosphere limitation belong in accessible provenance, assumptions and references. Simplifying the main interface does not remove the source record or change the scientific meaning of the retained Hb and O₂ qualifiers. [C9]
17 Misconception safeguards
Misconception | Required safeguard
Anyone can become Everest Established | No A/D/E control at either extreme; source-specific reference label.
Selecting Everest means acute arrival | Explicit selected acclimatized reference; no journey or elapsed time.
Surviving a sample implies stability or safety | Rest is a sampling condition; no survival, illness or sustainability prediction.
Chamber altitude is field altitude | Keep actual PB, FiO₂ and source setting in provenance.
8400 m arterial samples were summit samples | Retain exact sampling altitude in evidence and source notes.
Source means describe an average unselected person | State selection, small n, attrition and protocol-specific conditioning.
Calculated SaO₂ equals measured co-oximetry or pulse SpO₂ | Preserve measurement method; no algorithm agreement labelled independent validation.
Fixed-BPG P50 is whole-blood acclimatization | Theory qualifier; no extreme SaO₂ or arterial marker.
O₂ does not change ventilation | Fixed CO₂ is the equation comparison assumption, not a response claim.
All higher-altitude outputs must fall | PB, Dry PO₂ and PIO₂ must fall continuously with altitude at fixed gas. Physiological outputs may be non-monotonic across different study reference states.
Exact numerical checkpoints imply biological certainty | Full precision only in audit; rounded displays and explicit provenance.
Comparison records treatment recovery | Frozen state; net-difference arrows only.
Named landmarks reproduce local weather | Use one reference atmosphere throughout; names identify elevation context. Latitude, season, temperature and weather remain real-world limitations.

18 Claim by claim scientific decisions
LOCK denotes the retained scientific contract and the instructor-approved decisions synchronized here. The v1.1 supersession is limited to the conceptual and wording refinements identified in the amendment record. Implementation and release verification remain separate tasks. [C9–C10]
Claim or behavior | Decision | Rationale and implementation instruction
Extend the calibrated A/D/E surface to summit | REJECT | Evidence is not a universal altitude-by-acclimatization grid. Add a distinct class.
Add source-specific extreme references | LOCK WITH QUALIFIER | Use only the bounded states in Sections 8–9; no physiological interpolation between landmarks.
Logan input 20.0/7.51 | LOCK WITH QUALIFIER | Nearby chamber acid–base analogue and capillary CO₂ surrogate, R2–R3.
Everest input 11.2/7.56 | LOCK WITH QUALIFIER | Coherent R4 resting arterial source tuple; source conditions remain visible.
Derive stored bicarbonate | LOCK AS MODEL ASSUMPTION | Use inverse HH at full precision; source bicarbonate is not altered.
Retain atmosphere and R 0.80 | LOCK | Preserve C1–C2; do not tune to an external saturation or pressure.
Logan PaO₂ | INSUFFICIENT EVIDENCE | No selected compatible arterial correction; output null.
Everest A–a 1.5 | LOCK AS MODEL ASSUMPTION | Transferred chamber-informed effective parameter, not universal biological constant.
Everest PaO₂ ≈28 | LOCK WITH QUALIFIER | Model-derived from the selected pressure/CO₂/correction; not measured summit value.
Extreme P50 and Hb curve | LOCK WITH QUALIFIER | Theoretical fixed-BPG acid–base component; central calculation only.
Extreme SaO₂ and arterial marker | REJECT FOR V1 | Conditional discrepancy and incomplete whole-blood affinity; keep null.
Extreme-specific BPG tuning | OUT OF SCOPE | Would change comparison meaning and require matched concentration conversions.
Extreme oxygen PAO₂ | LOCK AS MODEL ASSUMPTION | Conditional fixed-CO₂ equation result; arterial outputs unavailable.
Extend 50-mmHg O₂ correction | REJECT | No matching new calibration; no automatic domain extension.
Retain Comparison | LOCK | Frozen values, evidence class and support travel together.
Force monotonic EBC→Logan oxygenation | REJECT | Different reference protocols; disclose, do not retune.
Quantitative illness or intervention effects | OUT OF SCOPE | Preserve I5A–I5D meanings and isolation.
Correct Hb architecture in this audit | OUT OF SCOPE | Separate implementation correction; audit supplies inputs/outputs only.
Promote final V1 | OUT OF SCOPE | Requires instructor approval, implementation and independent verification.
Continuous schematic mountain | LOCK | One reference pressure–altitude relationship; PB, Dry PO₂ and PIO₂ decline with altitude at fixed gas. [C9]
Substitute local or expedition PB | REJECT | Named landmarks supply elevation context. Retain actual source pressure only in provenance; preserve the reference-atmosphere main state. [C9]
Concise primary reference and Comparison wording | LOCK | Use the approved wording in Section 16 while preserving study-specific detail in provenance. [C9]
Durable scientific provenance | LOCK | Every used source and modeling decision must remain in both the simulator and the eventual scientific documentation, with value-status distinctions. [C9]

19 Evidence to interface mapping
Evidence or assumption | Interface representation | Quantitative status
Reference atmosphere | One continuous schematic mountain and environmental readouts; concise reference-atmosphere note | Equation-derived; names give elevation context and do not select local meteorology.
Nearby chamber acid–base analogue | Logan reference label and Davenport point | Source-derived teaching inputs; capillary surrogate.
Summit-equivalent arterial chamber data | Everest label and Davenport point | Source-derived teaching inputs, selected cohort.
Transferred Everest A–a | Approximate PaO₂ in Inspired O₂ cascade | Model-derived arterial estimate; absent on O₂.
Fixed-BPG controlled affinity | Hb curve and model P50 with explicit qualifier | Theoretical component, not full acclimatized blood.
Unsupported arterial saturation | Unavailable text; no arterial marker | Null; never back-calculated from pulse oximetry.
Gas equation with fixed CO₂ | Conditional alveolar output during O₂ | Counterfactual equation comparison.
Different source conditioning | EXTREME-ALTITUDE REFERENCE badge and approved comparison safeguard | Different evidence basis, not a data-quality or accuracy score.
Snapshot without history | Single retained Comparison and exact Reset | Deterministic scenario semantics.
Detailed source record | Simulator provenance / assumptions / references and eventual Scientific & Model Summary | Preserve every source, model decision and cumulative value-provenance category.

20 Retained scientific implementation contract
The contract below is retained from v1.0, with the approved interpretation and wording synchronized through Sections 2.1, 15 and 16. It remains the scientific authority for a separate bounded implementation task. The existing central-calculation requirement and all quantitative fields are preserved. [C9–C10]
Required field or rule | Contract
stateClass | extreme_reference
referenceId | logan_oeiii_6000_acidbase_v1 or everest_oeii_rest_v1
landmark and altitude | Existing Mount Logan 5959 and Everest 8849 identifiers/inputs.
category | Not applicable; do not store Arrival, Developing or Established as active physiology.
sourceCondition | Source study IDs, actual/nominal altitude, PB provenance, gas setting, sample type, n, exposure and source-locator text.
acidBaseInputs | Logan CO₂ 20 and HCO₃⁻ 15.422374696613188; Everest CO₂ 11.2 and HCO₃⁻ 9.690345850505395. pH calculated centrally.
affinityInputs | 37°C; BPG 0.00465 mol/L; DKB paper2016. No additional Bohr correction.
air arterial calibration | Logan: null. Everest: effective A–a 1.5; calculate PaO₂ centrally.
oxygen arterial calibration | null at both extremes. Never default to 50.
outputSupport | Separate booleans/status enums for acid–base, alveolar PO₂, arterial PO₂, theoretical affinity, arterial saturation and marker.
SaO₂ and arterial marker | null at both extremes for both gases, even if the generic saturation function can return a number.
curveOutput | Central PO₂/occupancy pairs and P50, with affinityRole=acid_base_component. View consumes them without its own DKB equation.
O₂ role | conditional_fixed_reference_CO2; preserve reference chemistry/curve and label this assumption.
Comparison | Deep-frozen numerical snapshot plus all evidence/support metadata; one retained comparison.
Control transitions | Exactly as Section 14, including Arrival on return to calibrated high altitude.
Presentation | Sections 2.1, 12, 15 and 16 govern the schematic mountain, components, approved wording, markers and missing data. Section 20.2 governs durable provenance.
Model version | New explicit extension version and source IDs; existing model version preserved as provenance.
Reset | Existing global opening state and panel/overlay cleanup; no recovery physiology.

20.1 Superseded and preserved rules
After approval, the two landmarks gain only the per-output support listed above. Current AC-08 and AC-09 environmental-only Everest expectations must be replaced with new component-level expectations. Existing tests whose purpose is the absence of fabricated unsupported outputs must still pass against the new null policy. Do not count prior checks as validation of the new domain. [C1–C3]
Calgary–EBC numerical states, 10 air and 10 immediate-O₂ cases, gas constants, renal teaching categories, references, fixed-BPG meaning and unrelated UI behavior remain unchanged. I5A remains qualitative and isolated; I5B remains a pressure/inspired-oxygen overlay with no Gamow physiological response; I5C remains a qualitative mechanism; I5D remains scenario comparison without treatment recovery. Document only the explicit domain exceptions to their previous above-EBC wording. [C2, C4–C7]
20.2 Durable scientific provenance
Every literature source and modeling decision used for the extreme references must be preserved in both: (1) the simulator’s provenance, assumptions and references at an appropriate level; and (2) the eventual Life at Altitude Scientific & Model Summary / scientific implementation documentation. The concise primary interface does not replace either record. The research basis must not remain solely in development history. [C9]
For every value, preserve whether it is directly measured; a literature-informed transfer; an arterialized-capillary surrogate; equation-derived; model-derived; an effective model assumption; theoretical; or unavailable. These descriptors may be cumulative: Logan’s source PCO₂ is measured in arterialized-capillary blood, then transferred as an arterial surrogate. Keep source observations distinct from the model’s derived state and retain the full-precision inputs and explicit null outputs. [C9–C10]
Retain the exact reference IDs logan_oeiii_6000_acidbase_v1 and everest_oeii_rest_v1; source IDs R2–R3 for the Logan analogue and R4 for the Everest anchor; and the complete supporting reference register. Source altitude, actual pressure, inspired gas, sample type, exposure history and measurement-versus-calculation status remain part of the scientific record. Source pressure must not be confused with the continuous reference-atmosphere PB. [C9–C10]

Core model: I2-RC1, unchanged Calgary–EBC calibration. Extension: V1-RC2/extreme-reference-v1.1. RC2-A centralized Hb saturation and curves without scientific recalibration. Source observations are not independent validation of model output.